专家文章 | 王贵强

搜索
登录

热心肠智库专家文章 | 王贵强

2023

CAAn-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

J CLIN TRANSL HEPATO, 10.14218/JCTH.2022.00091

CAGlobal, regional, and national burdens of cirrhosis in children and adolescents aged under 19 years from 1990 to 2019

HEPATOL INT, 10.1007/s12072-023-10531-y

CACutaneous Deep Ulcerations as Initial Presentations of Granulomatosis with Polyangiitis: Two Case Reports and Differential Diagnosis

MED LITH, 10.3390/medicina59030563

CAHigh-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis

HEPATOL INT, 10.1007/s12072-022-10466-w

2022

CAGlobal Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030

CLIN EPIDEMIOL, 10.2147/CLEP.S389853

FASafety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial

J INFECT, 10.1016/j.jinf.2022.11.008

CACase report: Wallerian degeneration: The innate-immune response to adult-onset Still's disease peripheral nerve injury

FRONT NEUROL, 10.3389/fneur.2022.1016393

CADiagnostic and Predictive Values of Ferroptosis-Related Genes in Child Sepsis

Front Immunol, 10.3389/fimmu.2022.881914

CADose-response relationship between qAnti-HBc and liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase based on liver biopsy

J MED VIROL, 10.1002/jmv.27779

2021

CATranscriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA

JMCB, 10.1093/jmcb/mjab067

FACAGuidelines for Prevention and Treatment of Chronic Hepatitis B

J CLIN TRANSL HEPATO, 10.14218/JCTH.2021.00209

CAThe Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

HEPATOL INT, 10.1007/s12072-021-10170-1

CAFavipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial

INT IMMUNOPHARMACOL, 10.1016/j.intimp.2021.107702

CAProfiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status

J Autoimmun, 10.1016/j.jaut.2021.102596

2020

CA2019 Chinese Clinical Practice Guidelines for the Prevention of Mother-to-child Transmission of Hepatitis B Virus

Journal of Clinical & Translational Endocrinology, 10.14218/JCTH.2020.00070

CATocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size

BIOMED PHARMACOTHER, 10.1016/j.biopha.2020.110825

CAEfficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial

Trials, 10.1186/s13063-020-04399-8

The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial

Trials, 10.1186/s13063-020-04430-y

FAFabrication of a mesoporous silica film based optical waveguide sensor for detection of small molecules

APPL OPTICS, 10.1364/AO.389118

CARapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study

HEPATOL INT, 10.1007/s12072-020-10015-3